LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 62 filers reported holding LEGEND BIOTECH CORP in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $310,394,854 | -5.2% | 4,621,034 | -2.6% | 0.01% | 0.0% |
| Q2 2023 | $327,450,294 | +64.5% | 4,743,594 | +14.9% | 0.01% | +50.0% |
| Q1 2023 | $199,049,894 | +2.8% | 4,127,953 | +6.5% | 0.01% | 0.0% |
| Q4 2022 | $193,580,125 | +27.1% | 3,877,807 | +3.9% | 0.01% | +20.0% |
| Q3 2022 | $152,256,000 | -12.1% | 3,731,782 | +18.5% | 0.01% | -16.7% |
| Q2 2022 | $173,136,000 | +56.4% | 3,147,931 | +3.3% | 0.01% | +100.0% |
| Q1 2022 | $110,701,000 | -1.3% | 3,046,229 | +26.6% | 0.00% | 0.0% |
| Q4 2021 | $112,161,000 | +164.7% | 2,406,401 | +187.2% | 0.00% | +200.0% |
| Q3 2021 | $42,365,000 | +28.6% | 837,927 | +4.4% | 0.00% | 0.0% |
| Q2 2021 | $32,947,000 | +443.2% | 802,597 | +284.1% | 0.00% | – |
| Q1 2021 | $6,065,000 | +11.9% | 208,979 | +8.6% | 0.00% | – |
| Q4 2020 | $5,419,000 | – | 192,472 | +2405800.0% | 0.00% | – |
| Q2 2020 | $0 | – | 8 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FengHe Fund Management Pte. Ltd. | 997,714 | $36,257,000 | 13.28% |
| JOHNSON & JOHNSON | 1,629,173 | $59,204,000 | 11.19% |
| Paradigm Biocapital Advisors LP | 831,728 | $30,225,000 | 7.99% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,100,542 | $39,994,000 | 5.54% |
| HHLR ADVISORS, LTD. | 6,936,617 | $252,077,000 | 5.26% |
| Old Well Partners, LLC | 79,700 | $2,896,000 | 1.94% |
| Parkman Healthcare Partners LLC | 120,473 | $4,378,000 | 1.28% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 4,500 | $5,632,000 | 1.27% |
| AtonRa Partners | 50,928 | $1,851,000 | 1.00% |
| Avidity Partners Management LP | 1,095,000 | $39,792,000 | 0.83% |